Page last updated: 2024-11-07

methylprednisolone acetate and Albers-Schoenberg Disease

methylprednisolone acetate has been researched along with Albers-Schoenberg Disease in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Aubaidi, Z1
Pedersen, NW1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Results of Multiple Aspirations and Injections of Unicameral Bone Cyst by Methyl Prednisolone Acetate[NCT03724630]15 participants (Anticipated)Observational2019-01-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for methylprednisolone acetate and Albers-Schoenberg Disease

ArticleYear
A bone cyst treated with corticosteroid installation in an osteopetrotic child.
    Journal of pediatric orthopedics, 2010, Volume: 30, Issue:2

    Topics: Anti-Inflammatory Agents; Bone Cysts; Child; Femur; Follow-Up Studies; Glucocorticoids; Humans; Inje

2010